Minireviews
Copyright ©The Author(s) 2023.
World J Stem Cells. Apr 26, 2023; 15(4): 221-234
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.221
Figure 1
Figure 1 Immune pathways in graft-versus-host disease and sites where therapy is used to block graft-versus-host disease development (red bars). APC: Antigen-presenting cell; ATG: Antithymocyte globulin; CSA: Cyclosporine A; DAMPs; Damage-associated molecular patterns; Foxp3+: Forkhead box P3; GCs: Glucocorticosteroids; GVHD: Graft-versus-host disease; MSC: Mesenchymal stem cell; TNF: Tumor necrosis factor; NK: Natural killer cells; PAMPs: Pathogen-associated molecular patterns.